Cargando…
Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients
SIMPLE SUMMARY: T1 laryngeal carcinoma arising from the vocal cords (glottis) is a highly curable disease with local control (LC) rates of over 90% by either primary radiotherapy (pRT) or transoral laser microsurgery (TLM). For slightly larger glottic tumors (T2), the outcome is significantly poorer...
Autores principales: | Dyckhoff, Gerhard, Warta, Rolf, Herold-Mende, Christel, Rudolph, Elisabeth, Plinkert, Peter K., Ramroth, Heribert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037641/ https://www.ncbi.nlm.nih.gov/pubmed/33807125 http://dx.doi.org/10.3390/cancers13071601 |
Ejemplares similares
-
Chemoradiotherapy but Not Radiotherapy Alone for Larynx Preservation in T3. Considerations from a German Observational Cohort Study
por: Dyckhoff, Gerhard, et al.
Publicado: (2021) -
An Observational Cohort Study on 194 Supraglottic Cancer Patients: Implications for Laser Surgery and Adjuvant Treatment
por: Dyckhoff, Gerhard, et al.
Publicado: (2021) -
Organerhalt: Entscheidungskriterien für Patienten mit T3-Larynxkarzinom
por: Dyckhoff, Gerhard, et al.
Publicado: (2022) -
Larynxorganerhalt bis zum T4‑Larynxkarzinom?
por: Dyckhoff, Gerhard, et al.
Publicado: (2022) -
Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma
por: Dyckhoff, Gerhard, et al.
Publicado: (2022)